SCHEMBL4375143

SCHEMBL4375143

CC(C)(C)N(C(=O)O)c1cccc(C(=O)Nc2ccc(Nc3cc(-c4cccc5c4oc4ccccc45)ncn3)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIP4K2C Q8TBX8 2/20 0.43
PIP4K2A P48426 3/20 0.39
PIP4K2B P78356 3/20 0.39
PIKFYVE Q9Y2I7 1/20 0.39
ABL1 P00519 2/20 0.39
BCR P11274 2/20 0.39
EGFR P00533 2/20 0.39
ERBB3 P21860 2/20 0.39
CYP1A2 P05177 3/20 0.37
ALDH1A1 P00352 2/20 0.37
CLK4 Q9HAZ1 2/20 0.37
CYP2D6 P10635 2/20 0.37
TSHR P16473 2/20 0.37
CYP3A4 P08684 1/20 0.37
MAPK1 P28482 1/20 0.37
CYP2C19 P33261 1/20 0.37
CDK9 P50750 4/20 0.37
SIRT1 Q96EB6 1/20 0.37
MCHR1 Q99705 1/20 0.37
NPC1 O15118 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4370078 0.95 PIP4K2C (0.46) PIP4K2CPIP4K2APIP4K2BPIKFYVEEGFR
SCHEMBL28526844 0.93 PIP4K2C (0.41) PIP4K2CPIP4K2APIP4K2BPIKFYVEABL1
SCHEMBL1243658 0.90 ABL1 (0.49) PIP4K2CPIP4K2APIP4K2BPIKFYVEABL1
SCHEMBL1243893 0.88 PIP4K2C (0.51) PIP4K2CPIP4K2APIP4K2BPIKFYVEEGFR
SCHEMBL4375779 0.88 PIP4K2C (0.50) PIP4K2CPIP4K2APIP4K2BPIKFYVEEGFR
SCHEMBL4372010 0.88 PIP4K2C (0.40) PIP4K2CPIP4K2APIP4K2BPIKFYVECYP1A2
SCHEMBL4378671 0.87 ADORA2A (0.42) PIP4K2CPIP4K2APIP4K2BPIKFYVEABL1
SCHEMBL16415895 0.86 PIP4K2C (0.46) PIP4K2CPIP4K2APIP4K2BPIKFYVEABL1
SCHEMBL28532461 0.86 PIP4K2C (0.45) PIP4K2CPIP4K2APIP4K2BPIKFYVEABL1
SCHEMBL4378412 0.85 PIP4K2C (0.46) PIP4K2CPIP4K2APIP4K2BPIKFYVEEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763526-B1 4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS BAYER SCHERING PHARMA AG (DE) 2009-06-24 EP claimed